Skin secretions from South America’s Paradoxical frog could be used to treat Type 2 diabetes, according to research announced at Diabetes UK’s Annual Professional Conference in Glasgow.
The researchers have tested a synthetic version of the peptide and found it could be used to produce a drug that stimulates the production of insulin. The treatment could be part of a new class of drugs called incretin mimetics.